Dingbo Shi
Impact in
-
- Circadian rhythm and melatonin
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cancer-related molecular mechanisms research 5
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Wuguo DengJingshu WangXiangsheng XiaoTiebang KangWenlin HuangLingyi FuLiqun LiuWangbing Chen
- Journals
- Oncotarget (10 papers)PLoS ONE (7 papers)Journal of Pineal Research (2 papers)Molecular Oncology (2 papers)Cell Death and Disease (2 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Dingbo Shi
45 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 102
- Endocrine and Autonomic Systems 223
- Cancer Research 362
- Biological Psychiatry 39
- Molecular Biology 990
- Oncology 347
Countries citing papers authored by Dingbo Shi
This map shows the geographic impact of Dingbo Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingbo Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingbo Shi more than expected).
Fields of papers citing papers by Dingbo Shi
This network shows the impact of papers produced by Dingbo Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingbo Shi. The network helps show where Dingbo Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Dingbo Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 23 | |
| 2 | 2023 | 10 | |
| 3 | 2023 | 0 | |
| 4 | 2021 | 11 | |
| 5 | 2020 | 12 | |
| 6 | 2019 | 28 | |
| 7 | 2019 | 29 | |
| 8 | 2018 | 25 | |
| 9 | 2017 | 25 | |
| 10 | 2017 | 55 | |
| 11 | 2014 | 11 | |
| 12 | 2014 | 24 | |
| 13 | 2014 | 33 | |
| 14 | 2013 | 57 | |
| 15 | 2013 | 100 | |
| 16 | 2013 | 29 | |
| 17 | 2012 | 62 | |
| 18 | 2012 | 62 | |
| 19 | 2011 | 209 | |
| 20 | 2010 | 31 |
About Dingbo Shi
Dingbo Shi is a scholar working on Cancer Research, Toxicology, Molecular Biology, Oncology and Biological Psychiatry, having authored 46 papers that have together received 1.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), Ubiquitin and proteasome pathways (5 papers), Cancer-related molecular mechanisms research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), RNA Research and Splicing (5 papers), Cancer-related gene regulation (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Endocrine and Autonomic Systems (223 citations), Cancer Research (362 citations), Biological Psychiatry (39 citations), Molecular Biology (990 citations) and Oncology (347 citations). Dingbo Shi has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Wuguo Deng, Jingshu Wang, Xiangsheng Xiao, Tiebang Kang, Wenlin Huang, Lingyi Fu, Liqun Liu, Wangbing Chen, Wei Guo and Xiaoming Xie. Their work appears in journals such as Oncotarget, PLoS ONE, Journal of Pineal Research, Molecular Oncology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.